Johannes vom Berg

Company: InCephalo

Job title: CSO

Seminars:

Leveraging Combination Checkpoint Inhibitors to Regulate Immunological Responses & “Flip” the Tumor Microenvironment 11:45 am

Examining the molecular pathways which modulate T-cell activation and immune response in the GBM tumor microenvironment Reprogramming the tumor microenvironment by enhancing cytotoxic T-cell infiltration and reducing regulatory T-cell activity within GBM, effectively “flipping” the tumor microenvironment Investigating synergistic effects in combination therapies with the potential of combining checkpoint inhibitors with other immunotherapies or standard…Read more

day: Conference Day 1